NIH-funded research R01 grant

Developing tools for precise genome editing

Official title: Computational tools for precision genome editing

Funded at Boston Children's Hospital · NIH-11138708 · Data updated 2026-11-12

This study is working on new tools to make genome editing safer and more effective for medical treatments, helping doctors better predict how these changes might affect your DNA.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBoston Children's Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startJuly 15, 2024
Project endApril 30, 2028
Funding year2025
Award (this year)$751,289
NIH project number5R01HG013618-02
Project IDNIH-11138708 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with genetic conditions that could potentially be treated through genome editing, such as beta-thalassemia.

Less likely to help

Patients with conditions that are not amenable to genome editing or those who do not have genetic mutations may not benefit from this research.

What this research studies

This research focuses on creating advanced computational tools to improve the safety and effectiveness of genome editing technologies. It aims to enhance the prediction of both on-target and off-target effects, which are crucial for the clinical application of these technologies. The project will refine existing tools and develop new ones to better understand the complexities of DNA modifications, ensuring that genome editing can be applied safely in medical treatments. By leveraging diverse human genomes and advanced sequencing methods, the research seeks to provide a clearer picture of how genome editing can be optimized for patient care.

Why it matters

Potential benefit: If successful, this research could lead to safer and more effective genome editing therapies for patients with genetic disorders.

How similar studies have gone: Previous research has shown promise in developing computational tools for genome editing, indicating that this approach has the potential for significant advancements.

Where this research is happening

  • Boston Children's Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Bauer, Daniel Evan — Boston Children's Hospital
  • Study coordinator: Bauer, Daniel Evan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.